Active
Overview
- Legal name
- PHADIA US INC
- Registered location
- PORTAGE, MI, USA
- Website
- Company website ↗
- Primary NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- Latest award activity
- Aug 26, 2026
Read company summary
PHADIA US INC is associated with UEI DK4EVCWUNUM4 and CAGE 1QNW5 in public federal records. AcornBids currently links 31 prime awards totaling $2.0M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as In-Vitro Diagnostic Substance Manufacturing; Electronic and Precision Equipment Repair and Maintenance. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325413 (In-Vitro Diagnostic Substance Manufacturing). Its public SAM.gov registration lists PORTAGE, MI, USA.
At a glance
Lifetime prime obligations$2.0M
Prime awards31
Awards with future end dates3
Top-agency concentration83.4%
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 9, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- PHADIA US INC
- UEI
- DK4EVCWUNUM4
- CAGE
- 1QNW5
- Registered address
- 4169 COMMERCIAL AVE, PORTAGE, MI, 49002, USA
- Registration status
- Active
- Primary NAICS
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- SAM activation
- Oct 17, 2025
- Initial registration
- May 20, 2004
- Entity start
- Feb 27, 2004
- SAM updated
- Oct 17, 2025
- Registration expires
- Oct 15, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 31 awards and $1,953,017 in reported obligations to this legal entity. Source
- Recorded awards include In-Vitro Diagnostic Substance Manufacturing (NAICS 325413); this classification is not proof of every company capability. Source
- An example award describes: SPECIFIC ANTI-ALPHA-GAL IMMUNOCAPTM PHADIA CORE LABORATORY TESTING PHADIA US INC:1109918 [26-008249] Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Selected transaction obligations$1.8M
Prime contracts
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 31 of 31 selected awards. Select a period to explore its awards.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $952.9K |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $719.9K |
| Change | $233.0K |
| Growth | +32.4% |
Where the work is performed
AKMEVTNHWAIDMTNDMNWIMINYMAORNVWYSDIAILINOHPANJCTRICAUTCONEMOKYWVVAMDDEAZNMKSARTNNCSCDCOKLAMSALGAHITXFL
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Defense | $1.4M | 26 |
| Department of Veterans Affairs | $284.2K | 3 |
| Department of Health and Human Services | $40.6K | 2 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| GPC COMPONENT PROGRAM MANAGER | $1.0M | 25 |
| DEFENSE HEALTH AGENCY HCD WEST | $416.0K | 1 |
| 262-NETWORK CONTRACT OFFICE 22 (36C262) | $247.7K | 2 |
| NATIONAL INSTITUTES OF HEALTH OLAO | $40.6K | 2 |
| 257-NETWORK CONTRACT OFFICE 17 (36C257) | $36.5K | 1 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 325413 — In-Vitro Diagnostic Substance Manufacturing | $1.7M | 30 |
| 811210 — Electronic and Precision Equipment Repair and Maintenance | $36.5K | 1 |
Psc
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| FA301624A0046 | $1.0M | 25 |
| Unclassified | $740.9K | 6 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| NO SET ASIDE USED. | $1.8M | 31 |
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N98026P01418SPECIFIC ANTI-ALPHA-GAL IMMUNOCAPTM PHADIA CORE LABORATORY TESTING PHADIA US INC:1109918 [26-008249] | Department of Health and Human Services | $22.6K | Aug 31, 2026 | Sep 30, 2026 |
| 36C25725C0001CTX HELIOS M&R | Department of Veterans Affairs | $36.5K | Oct 1, 2024 | Sep 30, 2027 |
| 36C26224P1907ANA TESTING ON HELIOS SYSTEM | Department of Veterans Affairs | $148.6K | Aug 31, 2024 | Feb 28, 2026 |
| HT009026FJ014LAB SUPPLIES FOR MEDICAL TREATMENT FACILITY | Department of Defense | $39.9K | May 28, 2026 | Sep 30, 2026 |
| 36C26226P0549HELIOS ANA TESTING SYSTEM REAGENTS, SUPPLIES, AND SERVICE | Department of Veterans Affairs | $99.2K | Mar 1, 2026 | Feb 28, 2027 |
| HT009026FH003AGENTS REQUIRED TO SCREEN BLOOD PRODUCTS. | Department of Defense | $49.9K | May 6, 2026 | Sep 30, 2026 |
| 75N98026P00380SPECIFIC IGE ALPHA-GAL TESTING ($30.00 UNIT (PER TEST) PRICE; $18,000.00 TOTAL TO TEST 600 FROZEN SERUM AND PLASMA BIOSPECIMENS) PHADIA US INC:1109918 [26-004781] | Department of Health and Human Services | $18.0K | Apr 30, 2026 | Apr 29, 2027 |
| HT009026FH024ESSENTIAL ITEMS FOR LAB DUTIES ( IMMUNOCAP SPEC. IGE- CONJUGATE) | Department of Defense | $84.8K | Apr 20, 2026 | Sep 30, 2026 |
| HT009026FG0430035LABORATORY SUPPLIES. | Department of Defense | $39.9K | Apr 9, 2026 | Sep 30, 2026 |
| W81K0223P0115ALLERGY TESTING ANALYZER AND REAGENTS FOR TAMC, HAWAII. | Department of Defense | $596.5K | Oct 1, 2023 | Sep 30, 2026 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Oct 17, 2025 |
| Source loaded | Oct 17, 2026 |
| Initial registration | May 20, 2004 |
| Entity start | Feb 27, 2004 |
| Industry | Reported size status |
|---|---|
| 325413 — In-Vitro Diagnostic Substance Manufacturing | Not reported |
| 423450 — Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| DAVID S DOWDY | Government business | Contact method not published | SAM registration | Not available |
| RYAN KUSMACK | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325413 — In-Vitro Diagnostic Substance Manufacturing
- 423450 — Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
26 awards
7 awards
34 awards
3 awards
30 awards
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit